This week on Contemporary OB/GYN®: Jan. 24 to Jan. 28

Article

A look at what's coming to Contemporary OB/GYN® this week.

The effect of eating disorders in pregnancy on neurodevelopmental risk in infants

Eating disorders carry many risks. An investigation looks into whether they can increase the risk of certain neurodevelopmental conditions in the children of mothers with a history of eating disorders.

Read now

Pembrolizumab plus lenvatinib show promise in advanced endometrial carcinoma

The latest trial results showed statistically significant improvements in overall survival and progression-free survival.

Read now

Agile Therapeutics partners with Afayxs to expand access to Twirla®

Agile Therapeutics, Inc. recently announced a new alliance with Afaxys Pharma, LLC to promote levonorgestrel and ethinyl estradiol (Twirla®) transdermal system.

Read now

Check back soon for additional updates.

Recent Videos
JoAnn Pinkerton discusses elinzanetant's crucial role in VMS therapy | Image Credit: uvahealth.com
Empowering women to take charge of their health | Image Credit: © piecesofi.com - © piecesofi.com - stock.adobe.com.
Supporting women through menopause with knowledge and care | Image Credit: © SHOTPRIME STUDIO - © SHOTPRIME STUDIO - stock.adobe.com.
How fezolinetant revolutionizes non-hormonal menopause therapy | Image Credit: imsociety.org
Gulf War exposures linked to early menopause in women veterans | Image Credit: linkedin.com.
Vanessa Muñiz discusses benefits of clinical hypnosis against hot flashes | Image Credit: mindbodymedicine.artsandsciences.baylor.edu
Elinzanetant displays positive phase 3 safety and efficacy data against VMS | Image Credit: © toeytoey - © toeytoey - stock.adobe.com.
© 2024 MJH Life Sciences

All rights reserved.